New drug, fospropofol disodium: A propofol prodrug

AANA Journal

Volumn 77, Issue 4, 2009, Pages 301-308

  Welliver, Mark ^a   Rugari, Susan M ^a  

^a TEXAS CHRISTIAN UNIVERSITY   (United States)

Author keywords

2,6 Diisopropylphenoxymethyl phosphate disodium salt; Fospropofol disodium; Lipid based emulsion; Prodrug; Propofol

Indexed keywords

FENTANYL; FORMALDEHYDE; FORMIC ACID; FOSPROPOFOL; LUSEDRA; MIDAZOLAM; MORPHINE; PETHIDINE; PHENOL DERIVATIVE; PHOSPHATIDYLCHOLINE; PROPOFOL; SOYBEAN OIL; UNCLASSIFIED DRUG;

ANESTHESIA MECHANISM; APNEA; AQUEOUS SOLUTION; BACTERIAL INFECTION; CLINICAL TRIAL; CONTINUOUS INFUSION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG PENETRATION; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TRANSFORMATION; EMULSION; HUMAN; HYPERLIPIDEMIA; INJECTION PAIN; NONHUMAN; REVIEW; SEDATION; SINGLE DRUG DOSE;

ANESTHETICS, INTRAVENOUS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CLINICAL TRIALS AS TOPIC; CONSCIOUS SEDATION; DRUG MONITORING; EMULSIONS; HUMANS; METABOLIC CLEARANCE RATE; MODELS, CHEMICAL; PATIENT SELECTION; PRODRUGS; PROPOFOL; SOLUBILITY; SOLUTIONS;

EID: 68849113228     PISSN: 00946354     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Masaki Y, Tanaka M, Nishikawa T. Physicochemical compatibility of propofol-lidocaine mixture. Anesth Analg. 2003;97(6):1646-1651.
2. Lilley EMM, Isert PR, Carraso ML, Kennedy RA. The effect of the addition of lignocaine on propofol emulsion stability. Anaesthesia. 1996;51(9):815-818. (Pubitemid 26305857)
3. Park JW, Park ES, Chi SC, Kil HY, Lee KH. The effect of lidocaine on the globule size distribution of propofol emulsions. Anesth Analg. 2003;97(3):769-771.
4. Han J, Davis SS, Washington C. Physical properties and stability of two emulsion formulations of propofol. Int J Pharm. 2001;215(1-2):207-220. (Pubitemid 32206618)
5. Propofol (Diprivan) [package insert]. Deerfield, IL: Baxter; January 2007.
6. Fukada T, Osaki M. Microbial growth in propofol formulations with disodium edetate and the influence of venous access system dead space. Anaesthesia. 2007;62(6):575-580. (Pubitemid 46796318)
7. Bennett SN, McNeil MM, Bland LA, et al. Postoperative infections traced to an intravenous anesthetic, propofol. N Engl J Med. 1995;333(3):147-154.
8. Carrasko G, Molina R, Costa J, Soler JM, Cabré L. Propofol vs midazolam in short-, medium-, and long-term sedation of critically ill patients: A cost-benefit analysis. Chest. 1993;103(2):557-564. (Pubitemid 23070763)
9. Bairaktari A, Raitsiou B, Kokolaki M, et al. Respiratory failure after pneumonectomy in a patient with unknown hyperlipidemia. Anesth Analg. 2001;93(2):292-293, 2nd contents page. (Pubitemid 32701517)
10. -1) in critically ill, mechanically ventilated patients. Acta Anaesth Scand. 2004;48(3):302-307. (Pubitemid 38295341)
11. Hopkins P, Wu L, Hunt S, Brinton E. Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease. J Am Coll Cardiol. 2005;45(7):1003-1012. (Pubitemid 40432430)
12. Banaszczyk MG, Carlo AT, Millan V, et al. Propofol phosphate, a water-soluble propofol prodrug: in vivo evaluation. Anesth Analg. 2002;95(5):1285-1292, table of contents. (Pubitemid 35239126)
13. Trapani A, Laquintana V, Lopedota A, et al. Evaluation of new propofol aqueous solutions for intravenous anesthesia. Int J Pharmaceutics. 2004;278(1):91-98. (Pubitemid 38670440)
14. Wang H, Cork R, Rao A. Development of a new generation of propofol. Curr Opin Anaesthesiol. 2007;20(4):311-315. (Pubitemid 47051890)
15. Fechner J, Ihmsen H, Hatterschild D, et al. Pharmacokinetics and clinical pharmacodynamics of the new propofol prodrug GPI 15715 in volunteers [published correction appears in Anesthesiology. 2008;109(5):940]. Anesthesiology. 2003;99(2):303-313.
16. Albert A. Chemical aspects of selective toxicity. Nature. 1958;182(4633):421-422.
17. Rautio J, Kumpulainen H, Heimbach T, et al. Prodrugs: design and clinical applications. Nat Rev Drug Discov. 2008;7(3):255-270.
18. Stella V, Zygmunt JJ, Georg IG, Safadi MS, inventors; University of Kansas, assignee. Water soluble prodrugs of hindered alcohols. US patent 7,244,718. July 17, 2007. http://patft.uspto.gov/netacgi/nph-Parser?Sect1= PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum. htm&r=1&f=G&1=50&s1=7244718.PN.&OS=PN/7244718&RS=PN/ 7244718. Accessed May 16, 2008.
19. Schywalsky M, Ihmsen H, Tzabazis A, et al. Pharmacokinetics and pharmacodynamics of the new propofol prodrug GPI 15715 in rats. Eur J Anaesthesiol. 2003;20(3):182-190. (Pubitemid 36286285)
20. Struys MMRF, Vanluchene ALG, Gibiansky E, et al. AQUAVAN injection, a water-soluble prodrug of propofol, as a bolus injection: a phase I dose-escalation comparison with DIPRIVAN, part 2: pharmacodynamics and safety [published correction appears in Anesthesiology. 2008;109(5):940]. Anesthesiology. 2005;103(4):730-743.
21. Wagner C. Biochemical role of folate in cellular metabolism. In: Bailey LB, ed. Folate in Health and Disease. New York, NY: Marcel Dekker; 1995:23-42.
22. Gibiansky E, Struys MMRF, Gibiansky L, et al. AQUAVAN injection, a water-soluble prodrug of propofol, as a bolus injection: a phase I dose-escalation comparison with DIPRIVAN, part 1: pharmacokinetics [published correction appears in Anesthesiology. 2008;109(5):940]. Anesthesiology. 2005;103(4):718-729.
23. Dharshwar SS, Stella VJ. Your prodrug releases formaldehyde: should you be concerned? No! J Pharm Sci. 2008;97(10):4184-4193.
24. Fechner J, Ihmsen H, Hatterschild D, et al. Comparative pharmacokinetics and pharmacodynamics of the new propofol prodrug GPI 15715 and propofol emulsion [published correction appears in Anesthesiology. 2008;109(5):940]. Anesthesiology. 2004;101(3):626-639.
25. Kestenbaum B, Sampson JN, Rudser KD, et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol. 2005;16(2):520-528. (Pubitemid 41725150)
26. Gottardis M, Khünl-Brady KS, Koller W, Sigl G, Hackl JM. Effect of prolonged sedation with propofol on serum triglyceride and cholesterol concentrations. Br J Anaesth. 1989;62(4):393-396. (Pubitemid 19111719)
27. Schüttler J, Stoeckel H, Schwilden H. Pharmacokinetic and pharmacodynamic modeling of propofol (Diprivan) in volunteers and surgical patients. Postgrad Med J. 2005;61(suppl 3):53-54.
28. 50 for propofol at two clinical end-points. Br J Anaesth. 2003;90(2):127-131. (Pubitemid 36181954)
29. 50 of propofol for loss of consciousness and skin incision. Anesthesiology. 1994;81(4):820-828, 26A. (Pubitemid 24332614)
30. Forrest FC, Tooley MA, Saunders PR, Prys-Roberts C. Propofol infusion and the suppression of consciousness: the EEG and dose requirements. Br J Anaesth. 1994;72(1):35-41. (Pubitemid 24023559)
31. US Department of Health and Human Services, Food and Drug Administration. Briefing materials for the Anesthetic and Life Support Drugs Advisory Committee to the Division of Anesthesia, Analgesia, and Rheumatology Products (DAARP)/CDER/FDA, May 7, 2008: fospropofol disodium injection: NDA 22-244; MGI Pharma, Inc. http://www.fda.gov/OHRMS/DOCKETS/ac/08/briefing/2008-4354b1-02-MGI. pdf. Accessed May 21, 2008.
32. Chernik DA, Gillings D, Laine H, et al. Validity and reliability of the Observer's Assessment of Alertness/Sedation Scale: study with intravenous midazolam. J Clin Psychopharmacol. 1990;10(4):244-251. (Pubitemid 20319177)
33. Cohen LB, Rex DK, Kline J, Wang C. Patient and physician satisfaction with fospropofol disodium: results of a phase 3, randomized, double-blind trial evaluating fospropofol disodium for moderate sedation in patients undergoing colonoscopy [abstract]. Gastrointest Endosc. 2007;65(5):AB367. Abstract W1440.
34. Rex DK, Cohen LB, Kline J, Wang C. Fospropofol disodium for minimal-to-moderate sedation during colonoscopy produces clear-headed recovery: results of a phase 3, randomized, double-blind trial [abstract]. Gastrointest Endosc. 2007;65(5):AB367. Abstract W1441.
35. Rex DK, Cohen LB, Kline J, Wang C. Fospropofol disodium is effective and safe for minimal to moderate sedation in patients undergoing colonoscopy: results of a phase 3, randomized, double-blind trial [abstract]. Gastrointest Endosc. 2007;65(5):AB369. Abstract W1451.
36. Vornov J, Braitman D, Gibiansky E, Jones J. A phase 1, double-blind, placebo-controlled, parallel-design, drug interaction study of fospropofol disodium (FD) and premedication in healthy, adult subjects. Gastrointest Endosc. 2006;63(5):AB195. Abstract T1327.
37. Arrowsmith JB, Gerstman BB, Fleischer DE, Benjamin SB. Results from the American Society for Gastrointestinal Endoscopy/US Food and Drug Administration collaborative study on complication rates and drug use during gastrointestinal endoscopy. Gastrointest Endosc. 1991;37(4):421-427.
38. Geller E. From oral midazolam to propofol: a perspective [editorial]. Gastrointest Endosc. 2005;61(2):201-202. (Pubitemid 40261066)
39. Corman SL, Skledar SL. Use of lipid emulsion to reverse local anesthetic-induced toxicity. Ann Pharmacother. 2007;41(11):1873-1877.
40. Moore N, Kirton C, Bane J. Lipid emulsion to treat overdose of local anaesthetic [letter]. Anaesthesia. 2006;61(6):607. (Pubitemid 43740723)
41. Neff SPW, Stapelberg GF, Warmington A. Excruciating perineal pain after intravenous dexamethasone. Anaesth Intensive Care. 2002;30(3):370-371. (Pubitemid 34619032)
42. Perron G, Dolbec P, Germain J, Béchard P. Perineal pruritus after IV dexamethasone administration [letter]. Can J Anaesth. 2003;50(7):749-750. (Pubitemid 37321984)
43. Thomas VL. More on dexamethasone-induced perineal irritation [letter]. N Engl J Med. 1986;314(25):1643-1644.
44. Hudes G, Haas N, Yeslow G, et al. Phase 1 clinical and pharmacologic trial of intravenous estramustine phosphate. J Clin Oncol. 2002;20(4):1115-1127. (Pubitemid 34141857)
45. Eisai. FDA Approves LUSEDRA™ (fospropofol disodium) injection for monitored anesthesia care (MAC) sedation [press release]. http://www.eisai.com/ view-press-release.asp?ID=129&press=206. Accessed February 23, 2009.